Internal Server Error

Anygen - About the company

Anygen is an acquired company based in Gwangju (South Korea), founded in 2000. It operates as a Peptide API and drug developer for cancer & pain disorders. Anygen has raised an undisclosed amount in funding.

Company Details

AnyGen is a peptide-based company focussed on the GMP/Non-GMP manufacturing of custom, generic and catalog peptides as well as developing peptide-based drugs. Its Nano-Bio Research center provides the peptide manufacturing services. Its GIST unit is currently developing 3 candidates namely an anti-cancer agent for head & neck, a neuropathic peptide pain-killer and an oral delivery platform technology which are planned for licensing after the preclinical trials.
Key Metrics
Founded Year
2000
Location
Gwangju, South Korea
Stage
Acquired
Latest Funding Round
Employee Count
17 as on Aug 31, 2026
Exit Details
Acquired by HLB (Mar 11, 2025)

Anygen's acquisition details

Anygen got acquired by HLB on Mar 11, 2025.
Click here to take a look at Anygen's acquisition in detail
Sign up to download Anygen's company profile

Anygen's funding and investors

Anygen has raised funding over 1 round. Its latest funding round was a Unattributed round on 2014 for $*****. 1 investor participated in its latest round. Anygen has 8 institutional investors.

Here is the list of recent funding rounds of Anygen:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
2014
6893
Unattributed
8669
4322
1571
7442
lockAccess funding benchmarks and valuations. Sign up today!

Anygen's founders and board of directors

Founder? Claim Profile

Anygen's employee count trend

Anygen has 17 employees as of Aug 26. Here is Anygen's employee count trend over the years:
Employee count trend for Anygen
lockUncover Anygen's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Anygen's Investments and acquisitions

Anygen has made no investments or acquisitions yet.

Reports related to Anygen

Here is the latest report on Anygen's sector:

FAQs about Anygen

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford